Live Breaking News & Updates on Kendra Sweeney

Stay updated with breaking news from Kendra sweeney. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

NeoGenomics, Inc. (NASDAQ:NEO) Q1 2024 Earnings Call Transcript

NeoGenomics, Inc. (NASDAQ:NEO) Q1 2024 Earnings Call Transcript April 30, 2024 NeoGenomics, Inc. beats earnings expectations. Reported EPS is $-0.02, expectations were $-0.03. NEO isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the NeoGenomics First Quarter 2024 Financial […] ....

North Carolina , United States , La Jolla , New York , Jeff Sherman , Chris Smith , Trademark Office , Circuit Court , Federal Circuit Court , North Carolina District , Thanks Chris , Change Healthcare , Jeff Sherman , Chief Commercial Officer , Melody Harris , Kendra Sweeney , Chief Executive Officer , Revenue Cycle Management , Darren Stone , Chief Operations Officer ,

NeoGenomics, Inc. (NASDAQ:NEO) Q1 2024 Earnings Call Transcript

NeoGenomics, Inc. beats earnings expectations. Reported EPS is $-0.02, expectations were $-0.03. ....

North Carolina , United States , La Jolla , New York , Puneet Souda , Mark Massaro , Kendra Sweeney , Jeff Sherman , Ali Olivo , Chris Smith , Neogenomics Inc , Circuit Court , Trademark Office , Business Development , Call Transcript April , Neogenomics First Quarter , Results Conference Call , Vice President , Investor Relations , Chief Executive Officer , Chief Financial , Warren Stone , Chief Commercial Officer , Melody Harris , Chief Operations Officer , Executive Vice President ,

NeoGenomics Reports Fourth Quarter and Full Year 2023 Results

Fourth Quarter Revenue Increased 12% to $156 million;Full Year Revenue Increased 16% to $592 millionFORT MYERS, Fla. (BUSINESS WIRE) NeoGenomics, Inc. (Nasdaq: NEO) (the “Company”), a leading provider of oncology testing and global contract research services, today announced fourth quarter and full year 2023 resul. ....

United States , North Carolina , Fort Myers , Aliso Viejo , Research Triangle Park , San Diego , United Kingdom , Kendra Sweeney , Chris Smith , Neogenomics Inc , Exchange Commission , Company Annual Report On Form , Clinical Services , Company Advanced Diagnostics Division , Fourth Quarter Revenue Increased , Year Revenue Increased , Advanced Diagnostics , Adjusted Gross Profit , Adjusted Net , Adjusted Gross Profit Margin , Adjusted Net Loss , Adjusted Diluted , Investor Relations , Advanced Diagnostics Division , Privacy Practices , Annual Report ,

NeoGenomics, Inc. (NASDAQ:NEO) Q4 2023 Earnings Call Transcript

NeoGenomics, Inc. (NASDAQ:NEO) Q4 2023 Earnings Call Transcript February 20, 2024 NeoGenomics, Inc. beats earnings expectations. Reported EPS is $0.03, expectations were $-0.01. NEO isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the NeoGenomics Fourth Quarter and Full […] ....

Chris Smith , Alex Nowak , Jeff Sherman , Circuit Court , Clinical Services , Cambridge United Kingdom , Federal Circuit , Advanced Diagnostics , Breakout Stocks To Buy Right Now , Jeff Sherman , Fourth Quarter , Kendra Sweeney , Financial Results , Revenue Cycle Management , Clinical Services , Gross Profit ,

NeoGenomics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

FT. MYERS, Fla., January 02, 2024 NeoGenomics will participate at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco and will present on Monday, Jan. 8, 8:15 p.m. ET. ....

San Francisco , United States , Fort Myers , North Carolina , Aliso Viejo , United Kingdom , Research Triangle Park , San Diego , Kendra Sweeney , Company Advanced Diagnostic Division , Neogenomics Inc , Healthcare Conference , Investor Relations , Advanced Diagnostic Division , Pmorgan Healthcare Conference , Cancer Genetics , Business Wire ,